- Home
- BLTE vs SGHC Comparison
BLTE vs SGHC Comparison
Compare BLTE & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- SGHC
- Stock Information
- Founded
- BLTE 2018
- SGHC 2020
- Country
- BLTE United States
- SGHC Guernsey
- Employees
- BLTE N/A
- SGHC N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- SGHC Services-Misc. Amusement & Recreation
- Sector
- BLTE Health Care
- SGHC Consumer Discretionary
- Exchange
- BLTE Nasdaq
- SGHC Nasdaq
- Market Cap
- BLTE 1.7B
- SGHC 1.8B
- IPO Year
- BLTE 2022
- SGHC N/A
- Fundamental
- Price
- BLTE $57.60
- SGHC $4.10
- Analyst Decision
- BLTE Strong Buy
- SGHC Strong Buy
- Analyst Count
- BLTE 4
- SGHC 2
- Target Price
- BLTE $59.00
- SGHC $5.50
- AVG Volume (30 Days)
- BLTE 40.3K
- SGHC 438.2K
- Earning Date
- BLTE 11-12-2024
- SGHC 11-07-2024
- Dividend Yield
- BLTE N/A
- SGHC 4.87%
- EPS Growth
- BLTE N/A
- SGHC N/A
- EPS
- BLTE N/A
- SGHC 0.01
- Revenue
- BLTE N/A
- SGHC $1,618,776,385.00
- Revenue This Year
- BLTE N/A
- SGHC $11.34
- Revenue Next Year
- BLTE N/A
- SGHC $8.57
- P/E Ratio
- BLTE N/A
- SGHC $345.07
- Revenue Growth
- BLTE N/A
- SGHC 11.40
- 52 Week Low
- BLTE $31.01
- SGHC $2.63
- 52 Week High
- BLTE $57.82
- SGHC $4.25
- Technical
- Relative Strength Index (RSI)
- BLTE 83.16
- SGHC 68.01
- Support Level
- BLTE $55.63
- SGHC $3.96
- Resistance Level
- BLTE $56.37
- SGHC $4.25
- Average True Range (ATR)
- BLTE 1.65
- SGHC 0.11
- MACD
- BLTE 0.53
- SGHC 0.02
- Stochastic Oscillator
- BLTE 97.94
- SGHC 73.68
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.